“Recent research shows that individuals with long Covid were more likely to have autoimmunity markers in their blood than those who had recovered quickly or never contracted the virus.

Source: https://medcitynews.com/2023/02/investment-trends-and-innovation-medcity-invest-pitch-perfect/

The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation.

Source: https://www.etfdailynews.com/2023/12/09/nascent-biotech-otcmktsnbio-and-intercept-pharmaceuticals-nasdaqicpt-head-to-head-survey/